The Hindu·3 min read·medium
Emcure to take full control of Gennova Biopharma with ₹232 crore stake acquisition
T
The Hindu Bureau
✦AI Summary
Emcure Pharmaceuticals is acquiring the remaining 12.05% stake in Gennova Biopharmaceuticals for ₹232 crore to gain full control. The move includes a leadership transition to focus on biologics and biosimilars.
Emcure Pharmaceuticals on Monday (July 13, 2026) said it is acquiring remaining 12.05% stake in subsidiary Gennova Biopharmaceuticals in a ₹232 crore deal.
businesshealthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in